These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10309840)

  • 1. Practical thoughts on cost-benefit analysis and health services.
    Burchell A; Weeden R
    Health Trends; 1982 Aug; 14(3):56-60. PubMed ID: 10309840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic appraisal in health care 2. Economic appraisal and health service decision-making.
    Mooney G; Drummond M
    Hosp Health Serv Rev; 1981; 77(10):308-13. PubMed ID: 10309530
    [No Abstract]   [Full Text] [Related]  

  • 3. Choosing between projects. The use of graphs to evaluate the use of benefit/cost ratios in cost effectiveness studies.
    Buckingham JK
    Hosp Health Serv Rev; 1987 Nov; 83(6):268-71. PubMed ID: 10312314
    [No Abstract]   [Full Text] [Related]  

  • 4. Time for the economist and the surgeon to rub shoulders.
    Devlin B
    Health Soc Serv J; 1980 Jan; 90(4675):48-51. PubMed ID: 10309110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic appraisal in health care: 1. A guide to the methodology of economic appraisal.
    Drummond M; Mooney G
    Hosp Health Serv Rev; 1981 Oct; 77(9):277-82. PubMed ID: 10309502
    [No Abstract]   [Full Text] [Related]  

  • 6. Should clinicians have a role in financial decision making in the NHS?
    Ahmed F; Ahmed N; Lechler R; Briggs TR
    Br J Hosp Med (Lond); 2017 Jul; 78(7):366-367. PubMed ID: 28692357
    [No Abstract]   [Full Text] [Related]  

  • 7. Need for differential discounting of costs and health effects in cost effectiveness analyses.
    Brouwer WB; Niessen LW; Postma MJ; Rutten FF
    BMJ; 2005 Aug; 331(7514):446-8. PubMed ID: 16110075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unintended consequences of applying economic evaluation.
    Oliver A
    J Health Serv Res Policy; 2002 Jul; 7(3):129-30. PubMed ID: 12171741
    [No Abstract]   [Full Text] [Related]  

  • 9. The way through the 80s: the development of better tools for productivity and performance.
    Sanderson HF; Winyard GP; Carroll GD; Logan RF
    Hosp Health Serv Rev; 1981; 77(10):304-8. PubMed ID: 10309529
    [No Abstract]   [Full Text] [Related]  

  • 10. Should cost effectiveness analyses for NICE always consider future unrelated medical costs?
    van Baal P; Morton A; Brouwer W; Meltzer D; Davis S
    BMJ; 2017 Nov; 359():j5096. PubMed ID: 29127081
    [No Abstract]   [Full Text] [Related]  

  • 11. Managing the health service. 6. Cost benefit analysis--Does it benefit the Health Service?
    Vinten G
    Health Visit; 1984 Apr; 57(4):105-7. PubMed ID: 6423571
    [No Abstract]   [Full Text] [Related]  

  • 12. Where to draw the lifeline?
    Siva N
    Nat Clin Pract Urol; 2008 Dec; 5(12):637. PubMed ID: 19050707
    [No Abstract]   [Full Text] [Related]  

  • 13. Time to market nursing.
    Henry H
    Nurs Stand; 2016 Jun; 30(44):27. PubMed ID: 27353916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effective care.
    Greener M
    Health Serv J; 1995 Dec; 105(5483):suppl 5 p.. PubMed ID: 10154611
    [No Abstract]   [Full Text] [Related]  

  • 15. Viewpoint. Doctors' dilemma--the emerging dual role of clinicians.
    Cavenagh P
    J Manag Med; 1996; 10(5):4-7. PubMed ID: 10166032
    [No Abstract]   [Full Text] [Related]  

  • 16. Option appraisal. Going for the best option.
    Henderson J; Mooney G
    Health Soc Serv J; 1985 Nov; 95(4975):1472-3. PubMed ID: 10311385
    [No Abstract]   [Full Text] [Related]  

  • 17. A more cost-effective health service--two views.
    Hucklesby DJ
    Hosp Health Serv Rev; 1980 Jul; 76(7):244-7. PubMed ID: 10309215
    [No Abstract]   [Full Text] [Related]  

  • 18. A more cost-effective health service--two views.
    Williams A
    Hosp Health Serv Rev; 1980 Jul; 76(7):241-4. PubMed ID: 10309214
    [No Abstract]   [Full Text] [Related]  

  • 19. Value for money in the NHS.
    Woolley K
    Br J Hosp Med; 1997 Mar 5-18; 57(5):230-1. PubMed ID: 9176607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognizing diversity in public preferences: the use of preference sub-groups in cost-effectiveness analysis.
    Sculpher M; Gafni A
    Health Econ; 2001 Jun; 10(4):317-24. PubMed ID: 11400254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.